Zumenon^®
(estradiol)

• Non-equine
• Body-identical 17β estradiol

Zumenon^® is an estrogen only continuous HRT for women with or without a uterus. In general, treatment should start with Zumenon^® 1mg. Depending on the clinical response, the dosage can afterwards be adjusted to individual need. If the woman still has estrogen deficiency symptoms the dosage can be increased by using Zumenon^® 2mg.¹

Regime			Dose	Bone protection	Pack	Price (£)2
Zumenon®	Continuous Estrogen only		1mg		3x28	6.89
Zumenon®	Continuous Estrogen only		2mg		3x28	6.89

These products are additionally licensed for the prevention of osteoporosis in post-menopausal women at high risk of the future fractures who are intolerant of, or contraindicated for, other medical products.

Non-hysterectomised
Add a progestogen if used in women with a uterus. This could be a separately prescribed therapy such as a 52mg intrauterine delivery system with a license for endometrial protection or micronised progesterone. You may also consider a combined HRT preparation such as Femoston^® or Femoston^®-conti (estradiol + dydrogesterone).

The active ingredient, 17β-estradiol is a regulated bioidentical hormone (or body identical hormone) and is similar to its biological equivalent.³ It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms.

• Relief of estrogen-deficiency symptoms¹
• Relief of menopausal symptoms was achieved during the first few weeks of treatment¹
• Hot flushes have been shown to be significantly reduced with 1 mg and 2 mg 17β-estradiol at 4 weeks¹